血栓トランスレーショナルリサーチラボ List of Products and Services

This is the world's first thrombin generation test that quantifies the anticoagulant activity of TFPI. By comparing thrombin in the presence and absence of anti-TFPI neutralizing antibodies, specificity is improved, allowing for a new approach to analyze the function of TFPI in various diseases. ■Features of the TFPI Kit - The first thrombin generation test that quantifies the anticoagulant activity of TFPI - Improved detection sensitivity of TFPI activity by blocking the FVIII/FIXa coagulation pathway - Enhanced specificity by comparing TG in the presence and absence of anti-TFPI neutralizing antibodies

• reagent

It is a non-activated blood coagulation test that specifically measures and evaluates active blood coagulation substances. This test explores potential influences that trigger blood coagulation and can identify promoting substances contained in cell culture media, body fluids, and biological products. ■What is SMAT? It has high sensitivity in thrombin detection. Rapid thrombin generation test at the endpoint. A test targeting thrombin production in the early stages of coagulation initiation.

• reagent

The "SMAT-TF Kit" is a thrombin production testing tool that examines the initial prothrombinase complex formed through the tissue factor coagulation pathway. It has high specificity by inhibiting the FVIII-FIX coagulation pathway and can be used in research investigating thrombosis and coagulation abnormalities. 【Features】 ■ Measures the activity of the prothrombinase complex formed in plasma ■ Exhibits high sensitivity and characteristics in thrombin detection ■ Endpoint thrombin production test

• reagent

We offer a high-sensitivity thrombin generation test tool, the 'SMAT(R)-FVIII/IX Kit', which measures the prothrombinase complex formed through the crosstalk reaction between the tissue factor coagulation pathway and the factor VIII and factor IX pathways. This tool can be applied in research investigating blood coagulation abnormalities and changes in patients with thrombosis or bleeding disorders. Please feel free to consult us if you have any requests. 【Features】 - Coagulation test targeting trace amounts of prothrombinase formed in the early stages of coagulation - Quantification of thrombin dependent on crosstalk reactions - Evaluation of the functional enhancement or reduction of the tissue factor coagulation pathway - Assessment of the reduced activity of factor VIII and factor IX, as seen in hemophilia - Evaluation of inhibitors against activated factor X and factor XI *For more details, please download the PDF or feel free to contact us.

• Other analytical and testing equipment